60 Views | 31 Downloads
Correspondence: Sonia Villapol, Ph.D., 6670 Bertnet Avenue, Houston, TX, 77030., svillapol@houstonmethodist.org
T.W.O. and C.P. performed the statistical analysis. S.L.L., T.W.O., C.P., R.S., P.R., A.C. and S.V. performed the literature search, collected the data, wrote the manuscript, and made edits. S.L.L. and S.V. were mainly responsible for the interpretation of the data and preparing the final version. S.V. created the figures. All authors provided critical feedback and contributed to the final manuscript. Correspondence and requests for materials should be addressed to S.V.
The authors are solely responsible for all content, and funders played no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript. S.L.L. is an employee of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. The remaining authors have no competing interests to declare.
This article was funded by Houston Methodist Research Institute (S.V.).
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.